Rentschler Biopharma Appoints Dr. Veit Bergendahl as COO
Rentschler Biopharma has appointed Dr. Veit Bergendahl as Chief Operating Officer and executive board member, effective April 1, 2026. Dr. Bergendahl brings over 20 years of international leadership experience in biopharmaceutical development and manufacturing. He will oversee process development, cGMP manufacturing, engineering, technology, and production automation, contributing to the company's strategic direction and sustainable growth.
Theia Market Signal Identification - AI Assisted
Rentschler Biopharma has appointed Dr. Veit Bergendahl as Chief Operating Officer, effective April 1, 2026. He will be responsible for process development, clinical and commercial cGMP manufacturing, engineering and technology, and production automation.
With over 20 years of international leadership experience in biopharmaceutical development and manufacturing, Dr. Bergendahl will help shape the company's strategy and drive sustainable growth.
Comments